片山研究室
学術論文情報（Papers）
1. K. Terada, D. Asai, J-H. Kang, T. Mori, Y. Katayama, Activated tyrosine kinase c-Src-responsive artificial gene carrier: in vitro and in vivo evaluation, Chemistry Select, 9, e202303331 (2024).
https://doi.org/10.1002/slct.202303331
2. R. Yoshida, R. Kaguma, R. Kaneko, I. Matuso, M. Yoritate, G. Hirai, T. Teramoto, Y. Kakuta, K. Minamihata, N. Kamiya, T. Nii, A. Kishimura, T. Mori*, Y. Katayama*, Orthogonality of α-Sulfoquinovosidase in Human Cells and Development of Its Fluorescent Substrate, Sensor. Mater., 36, 3227–3238 (2024).
https://doi.org/10.18494/SAM4816
3. Y. Yagi, Y. Liu, J. Li, S. Shimada, M. Ohkouchi, Y. Taguchi, T. Nii, T. Mori*, Y. Katayama, Oral administration of PLGA nanoparticles to deliver antisense oligonucleotides to inflammatory lesions in the gastrointestinal tract, Biol. Pharm. Bull., 47, 848–855 (2024).
https://doi.org/10.1248/bpb.b23-00769
4. H. Tagawa, R. Saeki, C. Yamamoto, K. Tanito, C. Tanaka, S. Munekawa, T. Nii, A. Kishimura, H. Murakami, T. Mori*, Y. Katayama*, The effect of affinities to Fc region of protein-based ARMs on the antibody-dependent cellular cytotoxicity, RSC Adv., 14, 22860 (2024).
https://doi.org/10.1039/D4RA03391D
5. Y. C. Yee, T. Mori*, S. Ito, T. Taguchi, Y. Katayama, Impact of hydrophobic modification on biocompatibility Alaska pollock gelatin microparticles, Anal. Sci., 40, 2053–2061 (2024).
https://doi.org/10.1007/s44211-024-00643-2
6. Y. C. Yee, A. Nakamura, Y. Okada, T. Mori*, Y. Katayama, Establishment of an in vitro evaluation method for immunomodulatory functions of yeast strains, Anal. Sci., 40, 2043–2051 (2024).
https://doi.org/10.1007/s44211-024-00641-4
7. M. Najmina, R. Shimazui, S. Kobayashi, H. Takata, M. Shibata, K. Ishibashi, A. Kishimura, Y. Shiota, D. Ida, T. Shimizu, T. Ishida, Y. Katayama, M. Tanaka, T. Mori*, A Stealthiness Evaluation of Main Chain Carboxybetaine Polymer Modified into Liposome, Pharmaceutics, 16, 1271 (2024).
https://doi.org/10.3390/pharmaceutics16101271
8. K. Tanito, T. Nii* (co-first author), K. Wakuya, Y. Hamabe, T. Yoshimi, T. Hosokawa, A. Kishimura, T. Mori, and Y. Katayama*. “Inflammation-triggering engineered macrophages (MacTriggers) enhance reactivity of immune checkpoint inhibitor only in tumor tissues” Cancers, Vol. 16, 3787, 2024.
https://doi.org/10.3390/cancers16223787
9. T. Nii*, S. Hijii, R. Kaneko, K. Tanito, K. Yamanaka, A. Kishimura, T. Mori, and Y. Katayama*. “In vitro evaluation of novel SN-38 prodrug activated by α-rhamnosidase of exogenous enzyme” Anal. Sci., 40, 1529-1535, 2024.
https://doi.org/10.1007/s44211-024-00593-9
10. A. Goto, Y. Anraku, S. Fukushim, and *A.Kishimura, Polyion complex vesicles containing viscosity enhancer for sustained release of water-soluble low-molecular-weight drugs. Chem. Lett., 53, upae070 (2024).
https://doi.org/10.1093/chemle/upae070
総説・解説（Reviews）・著書(Books)
1. 森 健, 村上大輔, アレルゲン免疫療法用製剤の進歩, 臨床免疫・アレルギー科, 82, 434-438 (2024).
https://www.kahyo.com/product/detail/M202410
2. 新居 輝樹 『生体に腫瘍を排除させトリガーとして機能する遺伝子改変マクロファージ「マックトリガー」』 月刊BIOINDUSTRY 41巻3号, 75-58, 2024年
3. 岸村顕広、静電相互作用の設計に基づくポリイオンコンプレックスバイオマテリアルの創製〜膜と非膜の融合〜、膜（MEMBRANE）, 49, 337–344 (2024).
4. F. Aulia and *A. Kishimura, Recent Progress of Polyion Complex Vesicles (PICsomes) for Biomedical Applications. In: Kasai, H., Uji-i, H., Hofkens, J. (eds) “Nanomedicines for Effective Cancer Therapy,” Nanomedicine and Nanotoxicology, Springer, Singapore. pp. 149–183（総ページ数307ページ）. (Published online: Oct. 20, 2024).
https://doi.org/10.1007/978-981-97-5288-1_10
ISBN (print): 978-981-97-5287-4, ISBN (online): 978-981-97-5288-1
5. 岸村顕広、ポリイオンコンプレックス形成から考える生命現象理解と生体材料設計への合理的アプローチ、バイオマテリアル, 42, 134–139 (2024).
特許情報（Patents）
その他の活動（プレスリリース・新聞記事・広報資料・アウトリーチ情報等）
1. 新しい時代の博士を目指す「ジュニア科学者養成講座」ニュートンコース初級編（物理学・化学）第２期
化学の回を担当：2024/6/2, 9、福岡市科学館。主催：福岡市科学館
https://www.fukuokacity-kagakukan.jp/news/2024/03/newton.html
